These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 65219)
1. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines. Cloyd MW; Bolognesi DP; Bigner DD Cancer Res; 1977 Mar; 37(3):922-30. PubMed ID: 65219 [TBL] [Abstract][Full Text] [Related]
2. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on the surfaces of normal murine cells. Cloyd MW; Bolognesi DP; Bigner DD Cancer Res; 1977 Mar; 37(3):931-8. PubMed ID: 65220 [TBL] [Abstract][Full Text] [Related]
3. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells. Holder WD; Peer GW; Bolognesi DP; Wells SA Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944 [TBL] [Abstract][Full Text] [Related]
4. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus. Genovesi EV; Collins JJ J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299 [TBL] [Abstract][Full Text] [Related]
5. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia. Ishimoto A; Ito Y Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227 [No Abstract] [Full Text] [Related]
6. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice. Ishimoto A; Ito Y J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372 [No Abstract] [Full Text] [Related]
7. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152 [TBL] [Abstract][Full Text] [Related]
8. Intracellular localization of mammalian type C virus species-specific (gs-1) and interspecies-specific (gs-3) antigenic determinants with the indirect immunoperoxidase technique and light microscopy. Girardi A; Hampar B; Hsu KC; Oroszlan S; Hornberger E; Kelloff G; Gilden RV J Immunol; 1973 Jul; 111(1):152-6. PubMed ID: 4123368 [No Abstract] [Full Text] [Related]
9. Antigenic comparison of bovine type C virus with murine and feline leukemia viruses. Ferrer JF Cancer Res; 1972 Sep; 32(9):1871-7. PubMed ID: 4345040 [No Abstract] [Full Text] [Related]
10. Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. Ihle JN; Denny TP; Bolognesi DP J Virol; 1976 Mar; 17(3):727-36. PubMed ID: 56459 [TBL] [Abstract][Full Text] [Related]
11. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Glynn JP; McCoy JL; Fefer A Cancer Res; 1968 Mar; 28(3):434-9. PubMed ID: 4867923 [No Abstract] [Full Text] [Related]
12. Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses. Lee JC; Ihle JN J Natl Cancer Inst; 1975 Oct; 55(4):831-8. PubMed ID: 52718 [TBL] [Abstract][Full Text] [Related]
13. Specificity and distribution of the determinants of the major glycoprotein (gp71) of murine oncornaviruses as detected by an in vitro cytotoxicity assay. Collins JJ; Bolio LD; Denny TP; Bolognesi DP J Natl Cancer Inst; 1977 Jul; 59(1):99-106. PubMed ID: 69038 [No Abstract] [Full Text] [Related]
14. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens. Hanna MG; Ihle JN; Lee JC Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222 [TBL] [Abstract][Full Text] [Related]
15. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes. Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054 [TBL] [Abstract][Full Text] [Related]
16. Antigenic analysis of L strain cells: a new murine leukemia-associated antigen, "L". Leclerc JC; Levy JP; Varet B; Oppenheim S; Senik A Cancer Res; 1970 Jul; 30(7):2073-9. PubMed ID: 4318470 [No Abstract] [Full Text] [Related]
17. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis. BasombrÃo MA; Mayer AM; Pasqualini CD Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71. Lee JC; Ihle JN J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879 [TBL] [Abstract][Full Text] [Related]
19. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. Metzgar RS; Mohanakumar T; Bolognesi DP J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269 [TBL] [Abstract][Full Text] [Related]
20. Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30. Ikeda H; Pincus T; Yoshiki T; Strand M; August JT; Boyse EA; Mellors RC J Virol; 1974 Nov; 14(5):1274-80. PubMed ID: 4139291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]